1. Beyond outstanding results with VEGFR/PDGFR inhibitors in advanced hepatocellular carcinoma: can imaging help where biomarkers keep us waiting?

   • S. Faivre
   • E. Raymond

   Editorial 08 August 2007 Pages: 197 - 198

2. Molecular targeted therapy for advanced hepatocellular carcinoma

   • Ying Chun Shen
   • Chiun Hsu
   • Ann Lii Cheng

   Review 18 August 2007 Pages: 199 - 210

3. New angiogenic agents and non-small cell lung cancer: current results and future development

   • Antonio Rossi
   • Paolo Maione
   • Cesare Gridelli

   Review 01 September 2007 Pages: 211 - 223

4. The intersection of sunitinib with the immunosuppressive microenvironment of renal cell carcinoma: implications for future therapeutics

   • Renee N. Salas
   • James H. Finke
   • Brian I. Rini

   Review 18 October 2007 Pages: 225 - 234

   

5. Targeted therapy in hormone refractory prostate cancer

   • S. Burbridge
   • S. Chowdhury
   • P. G. Harper

   Review 16 October 2007 Pages: 235 - 240

6. Combining targeted therapies

   • Xabier García-Albeniz
   • Alejandro Martinez-Fernandez
   • Pere Gascon

   Review 07 September 2007 Pages: 241 - 252

7. Effect of cetuximab in recurrent and refractory squamous cell carcinoma of the head and neck (SCCHN): a case report

   • Clorinda Schettino
   • Maria Anna Bareschino
   • Fortunato Ciardiello

   Day-to-Day Practice 05 September 2007 Pages: 253 - 257